Giandomenica Iezzi
Giandomenica Iezzi
Ente Ospedaliero Cantonale, Svizzera
Verified email at eoc.ch
Title
Cited by
Cited by
Year
The duration of antigenic stimulation determines the fate of naive and effector T cells
G Iezzi, K Karjalainen, A Lanzavecchia
Immunity 8 (1), 89-95, 1998
9881998
From TCR engagement to T cell activation
A Lanzavecchia, G Iezzi, A Viola
Cell 96 (1), 1-4, 1999
4381999
A lymphotoxin-driven pathway to hepatocellular carcinoma
J Haybaeck, N Zeller, MJ Wolf, A Weber, U Wagner, MO Kurrer, J Bremer, ...
Cancer cell 16 (4), 295-308, 2009
3552009
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines
A Ronchetti, P Rovere, G Iezzi, G Galati, S Heltai, MP Protti, MP Garancini, ...
The Journal of Immunology 163 (1), 130-136, 1999
3311999
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey, C Nebiker, X Huber, I Zlobec, ...
European journal of cancer 49 (9), 2233-2242, 2013
3292013
Processing of engulfed apoptotic bodies yields T cell epitopes.
M Bellone, G Iezzi, P Rovere, G Galati, A Ronchetti, MP Protti, J Davoust, ...
The Journal of Immunology 159 (11), 5391-5399, 1997
2881997
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
A Lugli, G Iezzi, I Hostettler, MG Muraro, V Mele, L Tornillo, V Carafa, ...
British journal of cancer 103 (3), 382, 2010
2672010
The interplay between the duration of TCR and cytokine signaling determines T cell polarization
G Iezzi, E Scotet, D Scheidegger, A Lanzavecchia
European journal of immunology 29 (12), 4092-4101, 1999
2441999
GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survival
I Sonderegger, G Iezzi, R Maier, N Schmitz, M Kurrer, M Kopf
Journal of Experimental Medicine 205 (10), 2281-2294, 2008
2252008
CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells
G Iezzi, I Sonderegger, F Ampenberger, N Schmitz, BJ Marsland, M Kopf
Proceedings of the National Academy of Sciences 106 (3), 876-881, 2009
2002009
Migration and function of antigen-primed nonpolarized T lymphocytes in vivo
G Iezzi, D Scheidegger, A Lanzavecchia
Journal of Experimental Medicine 193 (8), 987-994, 2001
1912001
Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis
I Sonderegger, TA Röhn, MO Kurrer, G Iezzi, Y Zou, RA Kastelein, ...
European journal of immunology 36 (11), 2849-2856, 2006
1842006
Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis
U Eriksson, MO Kurrer, I Sonderegger, G Iezzi, A Tafuri, L Hunziker, ...
Journal of Experimental Medicine 197 (3), 323-331, 2003
1642003
Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection
G Iezzi, A Fröhlich, B Ernst, F Ampenberger, S Saeland, N Glaichenhaus, ...
The Journal of Immunology 177 (2), 1250-1256, 2006
1272006
CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’approach to tumour host interaction in colorectal cancer
A Lugli, E Karamitopoulou, I Panayiotides, P Karakitsos, G Rallis, G Peros, ...
British journal of cancer 101 (8), 1382, 2009
1052009
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes
A Camporeale, A Boni, G Iezzi, E Degl’Innocenti, M Grioni, A Mondino, ...
Cancer Research 63 (13), 3688-3694, 2003
972003
Tick saliva inhibits dendritic cell migration, maturation, and function while promoting development of Th2 responses
A Skallová, G Iezzi, F Ampenberger, M Kopf, J Kopecký
The Journal of Immunology 180 (9), 6186-6192, 2008
872008
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
F Amicarella, MG Muraro, C Hirt, E Cremonesi, E Padovan, V Mele, ...
Gut 66 (4), 692-704, 2017
802017
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma
G Sconocchia, I Zlobec, A Lugli, D Calabrese, G Iezzi, E Karamitopoulou, ...
International journal of cancer 128 (11), 2663-2672, 2011
802011
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker
G Sconocchia, S Eppenberger-Castori, I Zlobec, E Karamitopoulou, ...
Neoplasia (New York, NY) 16 (1), 31, 2014
782014
The system can't perform the operation now. Try again later.
Articles 1–20